Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymosin alpha1: a historical overview.

Enrico Garaci1

  • 1Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Presidenza@iss.it

Annals of the New York Academy of Sciences
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of hyaluronic acid and butyroyl glutathione in the management of glaucoma-related ocular surface disease: a prospective, interventional, double-blind, cross-over post market study.

Frontiers in pharmacology·2026
Same author

Photodynamic inactivation of Mycobacterium tuberculosis by broad-spectrum visible light.

Applied microbiology and biotechnology·2026
Same author

Updates on <i>Candida albicans</i> infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies.

Expert review of anti-infective therapy·2025
Same author

Innovative Approaches to Medical Rehabilitation: Regeneration, Immune Training, Homeostasis, and Microbiome Synergy.

International journal of molecular sciences·2025
Same author

Enteric delivery of indole-3-carboxylic acid unlocks therapeutic potential of postbiotic metabolite cascade.

International journal of pharmaceutics·2025
Same author

Impaired synaptic transmission and long-term potentiation in severe combined immunodeficient (SCID) mice.

Neuroreport·2025

Thymosin alpha 1 (Talpha1) enhances immune responses, proving effective in combination therapies against cancer and infections. Its immunomodulatory role is key for treating immunocompromised patients.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Thymosin alpha 1 (Talpha1) is an immunomodulating peptide isolated from the thymus.
  • Initial research focused on its potential in combination therapies.

Observation:

  • Talpha1 has demonstrated efficacy in inhibiting tumoral growth and controlling infections.
  • It is particularly beneficial for immunocompromised individuals.

Findings:

  • Talpha1 increases major histocompatibility complex (MHC) class-1 and Toll-like receptor expression.
  • It also enhances cytokine production, indicating a significant immunoregulatory role.

Implications:

  • These findings support the use of Talpha1 in clinical trials for hepatitis C and cancer.
  • Talpha1 shows promise as an adjunct therapy for various diseases.

Related Experiment Videos